Biomarkers Market – Blood-Based Neurodegeneration Testing Opening New Growth Frontier
Market OverviewBlood-based biomarkers are emerging as one of the most promising growth frontiers in neurodegenerative disease care. As Alzheimer’s and other dementias place increasing pressure on health systems, plasma-based tests are offering a scalable alternative to expensive imaging and invasive cerebrospinal fluid procedures. The Biomarkers Market was valued at USD 61.00 billion in...
0 Commentaires
0 Parts
196 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt